Sequential hepatectomy for hepatocellular carcinoma with inadequate future-liver-remnant after portal vein ligation in combination with apatinib plus camrelizumab (PLACES): a single-arm prospective pilot study.
Saved in:
| Title: | Sequential hepatectomy for hepatocellular carcinoma with inadequate future-liver-remnant after portal vein ligation in combination with apatinib plus camrelizumab (PLACES): a single-arm prospective pilot study. |
|---|---|
| Authors: | Zeng Z; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China., Huang H; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Zhu G; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Zeng J; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Ye X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Su H; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., He Y; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Jiang Y; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Su M; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Liu C; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Han C; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Liao X; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Mo N; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Ma F; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Li T; Department of Hepatobiliary Surgery, The Sixth Affiliated Hospital of Guangxi Medical University, Yulin, China., Zhou X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Liao J; Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Lv Z; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Luo W; Guangxi Key Laboratory of Longevity Science and Technology, AIage Life Science Corporation Ltd., Nanning, China., Wen Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Xu B; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Chen B; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Peng M; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Ma J; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Peng T; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. |
| Source: | Hepatobiliary surgery and nutrition [Hepatobiliary Surg Nutr] 2026 Feb 01; Vol. 15 (1), pp. 6. Date of Electronic Publication: 2025 Feb 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: AME Publishing Company Country of Publication: China (Republic : 1949- ) NLM ID: 101600750 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2304-3881 (Print) Linking ISSN: 23043881 NLM ISO Abbreviation: Hepatobiliary Surg Nutr Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41676759 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Sequential hepatectomy for hepatocellular carcinoma with inadequate future-liver-remnant after portal vein ligation in combination with apatinib plus camrelizumab (PLACES): a single-arm prospective pilot study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zeng+Z%22">Zeng Z</searchLink>; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Huang+H%22">Huang H</searchLink>; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Zhu+G%22">Zhu G</searchLink>; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Zeng+J%22">Zeng J</searchLink>; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Ye+X%22">Ye X</searchLink>; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Su+H%22">Su H</searchLink>; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22He+Y%22">He Y</searchLink>; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Jiang+Y%22">Jiang Y</searchLink>; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Su+M%22">Su M</searchLink>; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Liu+C%22">Liu C</searchLink>; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Han+C%22">Han C</searchLink>; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Liao+X%22">Liao X</searchLink>; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Mo+N%22">Mo N</searchLink>; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Ma+F%22">Ma F</searchLink>; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Li+T%22">Li T</searchLink>; Department of Hepatobiliary Surgery, The Sixth Affiliated Hospital of Guangxi Medical University, Yulin, China.<br /><searchLink fieldCode="AU" term="%22Zhou+X%22">Zhou X</searchLink>; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Liao+J%22">Liao J</searchLink>; Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Lv+Z%22">Lv Z</searchLink>; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Luo+W%22">Luo W</searchLink>; Guangxi Key Laboratory of Longevity Science and Technology, AIage Life Science Corporation Ltd., Nanning, China.<br /><searchLink fieldCode="AU" term="%22Wen+Z%22">Wen Z</searchLink>; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Xu+B%22">Xu B</searchLink>; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Chen+B%22">Chen B</searchLink>; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Peng+M%22">Peng M</searchLink>; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Ma+J%22">Ma J</searchLink>; Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Peng+T%22">Peng T</searchLink>; Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101600750%22">Hepatobiliary surgery and nutrition</searchLink> [Hepatobiliary Surg Nutr] 2026 Feb 01; Vol. 15 (1), pp. 6. <i>Date of Electronic Publication: </i>2025 Feb 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22AME+Publishing+Company%22">AME Publishing Company </searchLink><i>Country of Publication: </i>China (Republic : 1949- ) <i>NLM ID: </i>101600750 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2304-3881 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223043881%22">23043881 </searchLink><i>NLM ISO Abbreviation: </i>Hepatobiliary Surg Nutr <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41676759 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.21037/hbsn-24-363 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 6 Titles: – TitleFull: Sequential hepatectomy for hepatocellular carcinoma with inadequate future-liver-remnant after portal vein ligation in combination with apatinib plus camrelizumab (PLACES): a single-arm prospective pilot study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zeng Z – PersonEntity: Name: NameFull: Huang H – PersonEntity: Name: NameFull: Zhu G – PersonEntity: Name: NameFull: Zeng J – PersonEntity: Name: NameFull: Ye X – PersonEntity: Name: NameFull: Su H – PersonEntity: Name: NameFull: He Y – PersonEntity: Name: NameFull: Jiang Y – PersonEntity: Name: NameFull: Su M – PersonEntity: Name: NameFull: Liu C – PersonEntity: Name: NameFull: Han C – PersonEntity: Name: NameFull: Liao X – PersonEntity: Name: NameFull: Mo N – PersonEntity: Name: NameFull: Ma F – PersonEntity: Name: NameFull: Li T – PersonEntity: Name: NameFull: Zhou X – PersonEntity: Name: NameFull: Liao J – PersonEntity: Name: NameFull: Lv Z – PersonEntity: Name: NameFull: Luo W – PersonEntity: Name: NameFull: Wen Z – PersonEntity: Name: NameFull: Xu B – PersonEntity: Name: NameFull: Chen B – PersonEntity: Name: NameFull: Peng M – PersonEntity: Name: NameFull: Ma J – PersonEntity: Name: NameFull: Peng T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2026 Feb 01 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2304-3881 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Hepatobiliary surgery and nutrition Type: main |
| ResultId | 1 |
